NODULAR BASAL CELL CARCINOMA
Clinical trials for NODULAR BASAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NODULAR BASAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NODULAR BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needle-Free light therapy shows promise for common skin cancer
Disease control CompletedThis study tested a new way to treat basal cell carcinoma, a common skin cancer. Instead of surgery, doctors used a jet-injection device to deliver a drug called ALA into the tumor, then activated it with red light. The trial included 16 adults with small, low-risk BCCs and aimed…
Matched conditions: NODULAR BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
No-Needle chemo patch takes aim at skin cancer
Disease control CompletedThis study tested a microneedle patch that delivers the chemotherapy drug doxorubicin directly into nodular basal cell carcinoma, a common skin cancer. 90 adults with small, untreated tumors received either a low-dose, high-dose, or no-drug patch. The goal was to see if the patch…
Matched conditions: NODULAR BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC